The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...
Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...
13don MSN
New laser treatment could stop blindness even before it starts and restore early eye health
Scientists have developed a revolutionary laser treatment to prevent blindness. This non-invasive therapy uses ultra-short ...
2don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
WAUSAU, Wis. (WSAW) - Geographic atrophy affects approximately one million people in the United States and is commonly associated with both dry and wet macular degeneration. Now a new treatment is ...
Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, which is ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular degeneration, ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback